Expert Review of Anti-Infective Therapy

What do we mean by antibiotic resistance?
pp. 165-167(3)
Author: Bush, Karen

News in brief
pp. 169-171(3)

Disease Watch
pp. 172-172(1)

Lamivudine for chronic hepatitis B
pp. 173-180(8)
Author: Leung, Nancy

Coartemether (artemether and lumefantrine): an oral antimalarial drug
pp. 181-196(16)
Author: Wernsdorfer, Walther H

Recent advances in the treatment of HIV/AIDS
pp. 197-211(15)
Author: Steinhart, Corklin R

Therapeutic options for human herpesvirus-8/Kaposi’s sarcoma-associated herpesvirus-related disorders
pp. 213-225(13)
Authors: Aoki, Yoshiyasu; Tosato, Giovanna

Optimization of antibiotic dosing schedules in the light of increasing antibiotic resistance
pp. 227-234(8)
Authors: Smith, Susan V; Gould, Ian M

New antiviral therapies for hepatitis C
pp. 235-243(9)
Authors: O’Leary, Jacqueline; Chung, Raymond T

Endobronchial tuberculosis
pp. 245-251(7)
Author: Rikimaru, Toru

Recent advances in antifungal pharmacotherapy for invasive fungal infections
pp. 253-268(16)
Authors: Gallagher, Jason C; MacDougall, Conan; Dodds Ashley, Elizabeth S; Perfect, John R

New developments in antifungal strategy
pp. 269-277(9)
Authors: Shetty, Anjali; Barnes, Rosemary A

Progress in the treatment of a neglected infectious disease: visceral leishmaniasis
pp. 279-292(14)
Author: Murray, Henry W

Prevention and treatment of leptospirosis
pp. 293-298(6)
Authors: Edwards, Charles N; Levett, Paul N

Emerging infectious diseases: vulnerabilities, contributing factors and approaches
pp. 299-316(18)
Author: Lashley, Felissa R

Global dissemination of β2-lactamases mediating resistance to cephalosporins and carbapenems
pp. 317-327(11)
Author: Gootz, Thomas D